A research comparing the height of the bone after implant placement in sinus augmented Maxilla on both sides with comparisons of blood clot and Platelet Rich Fibri
- Registration Number
- CTRI/2023/08/056786
- Lead Sponsor
- Bathri Elangovan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Patient aged more than 18 years.
Patient with severe atrophy of the posterior maxilla with 4-6 mm of residual bone height.
Patient with a need for implant therapy in the bilateral posterior maxillary region.
Patient coming under the category of ASA I.
Patient with pathology-free sinus.
Patient being without active periodontal diseases.
Patient with systemic disease/condition that might interfere with implant placement.
Patient with active periodontal infection.
Patient with history of parafunctional habits.
Patient with habit of chronic smoking
Patient with habit of chronic alcoholics.
Patient undergoing corticosteroid therapy, chemotherapy, radiotherapy.
Pregnant females.
Patient with lack of stable posterior occlusion.
Patient with a history of maxillary sinus pathologic features and/or surgery.
Patient coming under the category of ASA II, III, IV
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Researcher will come to know whether blood clot alone provides better bone gain when <br/ ><br>compared with Platelet Rich Fibrin (PRF) after maxillary sinus augmentation with <br/ ><br>simultaneous implant placement.Timepoint: 6, 9 month
- Secondary Outcome Measures
Name Time Method Researcher will come to know whether blood clot alone provides better bone density when compared with Platelet Rich Fibrin (PRF) after maxillary sinus augmentation with <br/ ><br>simultaneous implant placement.Timepoint: 6, 9 month